Karen Jean Ferrante
CIK 1598502 · Head Res. & Dev. & Chief Med. · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$58.4K
Companies
6
Total Filings
63
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Director | — | $33.10 | — | $0 | 28 | 2026-06-11 |
| MGNX | Director | 14,750 | $3.96 | $58.4K | $0 | 12 | 2026-05-20 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 12 | 2020-10-02 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 6 | 2019-07-15 |
| Baxalta Inc (BXLT) Delisted | Director | 7,657 | — | — | $0 | 2 | 2016-05-12 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Head Res. & Dev. & Chief Med. | — | — | — | $0 | 1 | 2015-12-17 |
Recent Filings · Page 2 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-02 | COGT | Grant (A) | — | $0 | EDGAR |
| 2024-07-02 | COGT | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | COGT | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | MGNX | Exer (M) | +4,500 | $0 | EDGAR |
| 2024-04-02 | COGT | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | COGT | Grant (A) | — | $0 | EDGAR |
| 2023-10-03 | COGT | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | COGT | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | COGT | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.